rabeprazole has been researched along with Cancer of Gastrointestinal Tract in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marchetti, P | 1 |
| Milano, A | 1 |
| D'Antonio, C | 1 |
| Romiti, A | 1 |
| Falcone, R | 1 |
| Roberto, M | 1 |
| Fais, S | 1 |
1 trial available for rabeprazole and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial.
Topics: Administration, Metronomic; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dis | 2016 |